S
Suzanne Oparil
Researcher at University of Alabama at Birmingham
Publications - 941
Citations - 122414
Suzanne Oparil is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Blood pressure & Angiotensin II. The author has an hindex of 106, co-authored 885 publications receiving 113983 citations. Previous affiliations of Suzanne Oparil include Michigan State University & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Sex hormones and hypertension.
TL;DR: A discussion of the potential blood pressure regulating effects of female and male sex hormones, as well as the cellular, biochemical and molecular mechanisms by which sex hormones may modify the effects of hypertension on the cardiovascular system are provided.
Journal ArticleDOI
Effects of Dietary Sodium Reduction on Blood Pressure in Subjects With Resistant Hypertension: Results From a Randomized Trial
Eduardo Pimenta,Krishna K. Gaddam,Suzanne Oparil,Inmaculada Aban,Saima Husain,Louis J. Dell'Italia,David A. Calhoun +6 more
TL;DR: The results indicate that excessive dietary sodium ingestion contributes importantly to resistance to antihypertensive treatment and strategies to substantially reduce dietary salt intake should be part of the overall treatment of resistant hypertension.
Journal ArticleDOI
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.
David E. Kandzari,Deepak L. Bhatt,Sandeep Brar,Chandan Devireddy,Murray D. Esler,Martin Fahy,John M. Flack,Barry T. Katzen,Janice P. Lea,David P. Lee,Martin B. Leon,Adrian Ma,Joseph M. Massaro,Laura Mauri,Suzanne Oparil,William W. O'Neill,Manesh R. Patel,Krishna J. Rocha-Singh,Paul A. Sobotka,Laura P. Svetkey,Raymond R. Townsend,George L. Bakris +21 more
TL;DR: Post hoc analyses reveal several potential confounding factors that may partially explain the unexpected blood pressure responses in both the sham control and RDN groups.
Journal ArticleDOI
The impact of serum uric acid on cardiovascular outcomes in the LIFE study
Aud Høieggen,Michael H. Alderman,Sverre E. Kjeldsen,Stevo Julius,Richard B. Devereux,U de Faire,Frej Fyhrquist,Hans Ibsen,Krister Kristianson,Ole Lederballe-Pedersen,Lars H Lindholm,Markku S. Nieminen,Per Omvik,Suzanne Oparil,Hans Wedel,Cong Chen,Björn Dahlöf +16 more
TL;DR: The increase in SUA over 4.8years in the LIFE study was attenuated by losartan compared with atenolol treatment, appearing to explain 29% of the treatment effect on the primary composite end point.
Journal ArticleDOI
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension
Wilbert S. Aronow,Jerome L. Fleg,Carl J. Pepine,Nancy T. Artinian,George L. Bakris,Alan Brown,Keith C. Ferdinand,Mary Ann Forciea,William H. Frishman,Cheryl Jaigobin,John B. Kostis,Giuseppi Mancia,Suzanne Oparil,Eduardo Ortiz,Efrain Reisin,Michael W. Rich,Douglas D. Schocken,Michael Weber,Deborah J. Wesley +18 more
TL;DR: In this paper, Bhatt et al. discuss the role of race conditions in the development of FAHA and discuss the importance of race safety in the FAHA program and its role in FAHA.